• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Alfuzosin ER Teva
    / Abic

    Active Ingredient
    Alfuzosin HCl 10 mg

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Extended-Release Tablets

    30 X 10 mg

    not in the basket chart 24006 9412

    Related information


    One tablet a day, immediately after dinner. Swallow whole with water.
    Do not to crush, chew or divide the tablet.
    Start the therapy on the day of insertion of urethral catheter. Continue treatment for 3-4 days, i.e. 2-3 days during catheterization and 1 day following


    Treatment of certain functional symptoms of benign prostatic hypertrophy, particularly if surgery has to be delayed for some reason. Adjuvant treatment to a catheter in acute urinary retention related to benign prostates hypertrophy.


    Known hypersensitivity to the active ingredient, or to any component of the product. Postural hypotension, liver failure, severe kidney failure (creatinine clearance

    Special Precautions

    Contact distributing company for full details.

    Side Effects

    Contact distributing company for full details.

    Drug interactions

    Contact distributing company for full details.

    Unichem Laboratories